Stratasys' Objet Eden260V Wins "2013 Product Award - Top Innovative Equipment" from The Dental Advisor Magazine
The Objet Eden 3D Printer is the only rapid prototyping solution honored by the magazine this year

MINNEAPOLIS and REHOVOT, Israel, Jan. 23, 2013 /PRNewswire/ -- Stratasys Ltd. (NASDAQ: SSYS), a leading manufacturer of 3D printers and production systems for prototyping and manufacturing, today announced that the Objet Eden260V 3D Printer has been recognized as winner of the 2013 Product Award for Top Innovative Equipment by The Dental Advisor Magazine. The Objet 3D Printer was the only rapid prototyping platform honored in the magazine's annual innovation award list. The listing highlighted some of the key benefits of the Objet Eden260V including outstanding surface detail, easy management and maintenance, high resolution and speed.

"We are delighted that the Objet Eden260V 3D Printer was recognized by the prestigious Dental Advisor magazine," said Avi Cohen, Director of Global Dental at Stratasys Ltd. "This award reflects the growing importance of 3D printing in digitizing dentistry. Being placed in the Top Innovative Equipment category highlights Stratasys' important role in redefining manufacturing for dental laboratories."

3D printing is at the heart of the new digital era in dentistry. By combining oral scanning, CAD/CAM design and 3D printing, dental labs can accurately and rapidly produce dental stone models and a range of orthodontic appliances. The Objet Eden260V 3D Printer provides dental labs with an ideal platform for a digitized workflow, enabling more efficient, accurate and cost effective production.

"We are pleased about the continued recognition of the Objet Eden260V 3D Printer, which also won the "Readers' Choice" award from Dental Lab Productsmagazine in 2011," Cohen continued. "Stratasys will continue to innovate and deliver product excellence to the dental market."

Watch videos that show how customers are benefitting from the Objet Eden260V and learn more about Stratasys solutions for Dental Labs at www.ObjetDental.com, or contact us at dental@stratasys.com.

About Stratasys Ltd.Stratasys Ltd. (Nasdaq: SSYS) is the corporate entity formed in 2012 by the merger of 3D printing companies Stratasys, Inc. and Objet Ltd., based in Minneapolis, Minn. and Rehovot, Israel. The company manufactures 3D printers and materials for prototyping and production. Prior to merging, the two companies' revenues totaled $277 million for 2011. Its patented FDM® and inkjet-based PolyJet® processes produce prototypes or manufactured goods directly from 3D CAD files or other 3D content. Systems include affordable desktop 3D printers for idea development, a range of systems for prototyping, and large production systems for direct digital manufacturing. The company's range of more than 130 3D printing materials is believed to be the widest in the industry and includes over 123 proprietary inkjet-based photopolymer materials and 10 proprietary FDM-based thermoplastic materials. Stratasys also manufacturers Solidscape 3D Printers and operates the RedEye On Demand digital-manufacturing service. The company has over 1,100 employees, holds over 500 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership. Online at: www.stratasys.com or http://blog.stratasys.com / www.objet.com or http://blog.objet.com.

Cautionary Statement Regarding Forward-Looking Statements Statements regarding Stratasys' beliefs, intentions and expectations, including statements regarding the management of Stratasys, Inc. and Objet Ltd. as a combined company, the benefits of the combination of the companies, and the future financial performance of the combined company after their merger, are forward-looking statements. The statements involve risks and uncertainties, both known and unknown, that may cause actual results to differ materially from those projected. Actual results may differ materially due to a number of factors, including the risk and uncertainty that the businesses of the two companies may not be integrated successfully; the risk that the merger may involve unexpected costs or unexpected liabilities; the risk that synergies from the merger may not be fully realized or may take longer to realize than expected; the risk that management's focus on and disruptions arising from the merger make it more difficult to maintain relationships with customers, employees, or suppliers. Stratasys' ability to achieve the results presented in any forward-looking statement will depend on numerous factors, including its ability to penetrate the 3D printing market; its ability to achieve the growth rates experienced in preceding quarters; its ability to introduce, produce and market both existing and new consumable materials, and the market acceptance of these materials; the impact of competitive products and pricing; its timely development of new products and materials and market acceptance of those products and materials; the success of Stratasys' recent R&D initiative to expand the DDM capabilities of its core FDM technology; and the success of Stratasys' RedEye On DemandTM and other paid parts services. These and other applicable factors are discussed in this presentation and in Stratasys' filings with the Securities and Exchange Commission. These filings include the definitive proxy statement/prospectus filed with the SEC on August 8, 2012, as well as the filings that Stratasys, Inc. has made with the SEC and that Stratasys Ltd. has made and will make with the SEC in the future, including its report on Form 20-F to be filed for the year ended 12/31/2012. Any forward-looking statements included in this presentation are as of the date they are given, and Stratasys does not intend to update them if its views later change, except as may be required by law. These forward-looking statements should not be relied upon as representing Stratasys' views as of any date subsequent to the date they are given.